Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks
Title
Immunotherapy / Aung Naing, Joud Hajjar, editors.
Edition
Second edition.
ISBN
9783030025052 (electronic book)
3030025055 (electronic book)
9783030025045
Published
Cham, Switzerland : Springer, [2018]
Language
English
Description
1 online resource
Item Number
10.1007/978-3-030-02505-2 doi
Call Number
RC268.3 .I46 2018
Dewey Decimal Classification
616.994079
Summary
The second edition of Immunotherapy is an updated overview of immuno-oncology in acute myleloid leukemia, non-small cell lung cancer and sarcomas, showcasing advances in the management of cancer broadly classified as hematological malignancies, solid tumors and tumors arising in the connective tissue. Scientists, oncologists and advanced students will be provided with knowledge of basic immunology in the context of tumor biology, providing a comprehensive overview of the cellular components of the immune system that interact with each other to provide a successful immune response. A number of new, scientific findings in his fast moving field have necessitated a thoroughly updated and revised edition including the use of immunotherapy for gastrointestinal and genitourinary cancers, as well as discussions on optimizing radiotherapy with immunotherapeutic approaches, biomarkers of response or resistance to immunotherapy, cancer imaging in immunotherapy, skin reactions to immune checkpoint inhibitors and more. As immunotherapeutic agents differ significantly from chemotherapeutic agents in response patterns and toxicity profiles, evaluating their safety and efficacy in clinical trials remains a challenge. The new edition will discuss the use of a variety of traditional and new immunotherapy criteria to evaluate response, their inadequacies and clinical implications. Additionally, the book will outline how new advances in medical imaging technology has the potential to provide high-dimensional data to improve decision support and individualize treatment selection and monitoring. Edited by two renowned experts in the field, the book's chapters are written by a diverse cast of experts conducting cutting-edge research, providing the reader with the most up-to-date science.
Access Note
Access limited to authorized users.
Digital File Characteristics
text file PDF
Source of Description
Description based on online resource; title from digital title page (viewed on January 23, 2019).
Series
Advances in experimental medicine and biology ; v. 995.
Available in Other Form
Print version: 9783030025045
Overview of Basic Immunology and Translational Relevance for Clinical Investigators
Immunotherapy for Melanoma
Immunotherapy in Lung Cancer: A New Age in cancer treatment
Update on Immunotherapy in AML and MDS: Monoclonal Antibodies and Checkpoint Inhibitors Paving the Road for Clinical Practice
Skin Reactions to Immune Checkpoint Inhibitors
Immune-related Adverse Events: Pneumonitis
Immune checkpoint inhibitors-induced colitis
Immune checkpoint inhibitors-induced hepatitis
Symptoms as patient-reported outcomes in cancer patients undergoing immunotherapies.
